{"title":"EFFECTS OF <i>CLOSTRIDIUM BUTYRICUM</i> SUPPLEMENTATION ON FECAL MICROBIOTA AND METABOLITES IN CAPTIVE RED KANGAROO (<i>MACROPUS RUFUS</i>).","authors":"Yuto Yoshimoto, Natsumi Ichinohe, Hong Liu, Noriko Nagata, Ryo Inoue, Yuki Yamamoto, Kentaro Nagaoka","doi":"10.1638/2024-0079","DOIUrl":null,"url":null,"abstract":"<p><p>The red kangaroo (<i>Macropus rufus</i>) is a prominent marsupial species native to Australia and is kept in zoos worldwide. Captive red kangaroos are often plagued with several diseases, such as lumpy jaw, incurring high treatment costs. Recent research suggests a significant link between the gut microbiota and various diseases in many species, indicating potential benefits of probiotics in maintaining health. The microbiota of the digestive tract of red kangaroos has been reported; however, the fecal microbiota and any compositional changes in this microbiota caused by probiotic intervention remain to be elucidated. Herein, the effects of the probiotic <i>Clostridium butyricum</i>, which produces the short-chain fatty acid butyrate, on fecal microbiota and metabolites in red kangaroos were investigated. Fecal samples were collected from six red kangaroos free from signs of diseases (three males and three females, aged 1-2 yr) during <i>C. butyricum</i> supplementation and suspension periods. Fecal <i>C. butyricum</i> levels decreased during the suspension period and increased upon resumption by quantitative PCR analysis. Despite changes in <i>C. butyricum</i> levels, fecal concentrations of measured short-chain fatty acids remained unchanged. Total microbiome analysis showed no significant differences by <i>C. butyricum</i> supplementation. Functional predictions indicated alterations in microbial community functions, such as activating penicillin and cephalosporin biosynthesis and inactivating the bacterial secretion system during <i>C. butyricum</i> supplementation. Metabolomic analyses identified significant changes in pathways related to amino acid degradation and metabolism, fatty acid biosynthesis, glycolysis and glycogenesis, and the citrate cycle (the tricarboxylic acid cycle), suggesting that <i>C. butyricum</i> supplementation affects metabolism independent of microbiota composition. These findings suggest that <i>C. butyricum</i> alters metabolism. However, this study's kangaroos were supplemented with <i>C. butyricum</i> prior to the study period, so its impact could not be verified. Further study is also required to determine how these changes might contribute to maintaining health in captive red kangaroos.</p>","PeriodicalId":17667,"journal":{"name":"Journal of Zoo and Wildlife Medicine","volume":"56 2","pages":"360-370"},"PeriodicalIF":0.7000,"publicationDate":"2025-06-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of Zoo and Wildlife Medicine","FirstCategoryId":"97","ListUrlMain":"https://doi.org/10.1638/2024-0079","RegionNum":4,"RegionCategory":"农林科学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q3","JCRName":"VETERINARY SCIENCES","Score":null,"Total":0}
引用次数: 0
Abstract
The red kangaroo (Macropus rufus) is a prominent marsupial species native to Australia and is kept in zoos worldwide. Captive red kangaroos are often plagued with several diseases, such as lumpy jaw, incurring high treatment costs. Recent research suggests a significant link between the gut microbiota and various diseases in many species, indicating potential benefits of probiotics in maintaining health. The microbiota of the digestive tract of red kangaroos has been reported; however, the fecal microbiota and any compositional changes in this microbiota caused by probiotic intervention remain to be elucidated. Herein, the effects of the probiotic Clostridium butyricum, which produces the short-chain fatty acid butyrate, on fecal microbiota and metabolites in red kangaroos were investigated. Fecal samples were collected from six red kangaroos free from signs of diseases (three males and three females, aged 1-2 yr) during C. butyricum supplementation and suspension periods. Fecal C. butyricum levels decreased during the suspension period and increased upon resumption by quantitative PCR analysis. Despite changes in C. butyricum levels, fecal concentrations of measured short-chain fatty acids remained unchanged. Total microbiome analysis showed no significant differences by C. butyricum supplementation. Functional predictions indicated alterations in microbial community functions, such as activating penicillin and cephalosporin biosynthesis and inactivating the bacterial secretion system during C. butyricum supplementation. Metabolomic analyses identified significant changes in pathways related to amino acid degradation and metabolism, fatty acid biosynthesis, glycolysis and glycogenesis, and the citrate cycle (the tricarboxylic acid cycle), suggesting that C. butyricum supplementation affects metabolism independent of microbiota composition. These findings suggest that C. butyricum alters metabolism. However, this study's kangaroos were supplemented with C. butyricum prior to the study period, so its impact could not be verified. Further study is also required to determine how these changes might contribute to maintaining health in captive red kangaroos.
期刊介绍:
The Journal of Zoo and Wildlife Medicine (JZWM) is considered one of the major sources of information on the biology and veterinary aspects in the field. It stems from the founding premise of AAZV to share zoo animal medicine experiences. The Journal evolved from the long history of members producing case reports and the increased publication of free-ranging wildlife papers.
The Journal accepts manuscripts of original research findings, case reports in the field of veterinary medicine dealing with captive and free-ranging wild animals, brief communications regarding clinical or research observations that may warrant publication. It also publishes and encourages submission of relevant editorials, reviews, special reports, clinical challenges, abstracts of selected articles and book reviews. The Journal is published quarterly, is peer reviewed, is indexed by the major abstracting services, and is international in scope and distribution.
Areas of interest include clinical medicine, surgery, anatomy, radiology, physiology, reproduction, nutrition, parasitology, microbiology, immunology, pathology (including infectious diseases and clinical pathology), toxicology, pharmacology, and epidemiology.